SLC2A2 and Hypoinsulinemia: STZ enters B cells via a glucose transporter (GLUT2) using a variety of intracellular toxic mechanisms such as production of oxygen free radicals that causes degeneration of pancreatic B cells leading to hypoinsulinemia and subsequent hyperglycemia (33).